Raise the Caps
Research!America President and CEO, Mary Woolley, penned an op-ed for The Huffington Post about the urgent need for Congress to negotiate a budget deal to raise the federal spending caps to support science and innovation. “Members of Congress must recommit to driving scientific progress, a national imperative that is too easily taken for granted,” she wrote.
The St. Louis Post-Dispatch published a letter-to-the-editor written by Research!America Vice President of Communications Suzanne Ffolkes about the importance of raising budget caps. “Federal spending caps are limiting opportunities for scientists to launch and sustain research aimed at combating cancer, Alzheimer’s disease and many other health threats.”
In a U.S. News and World Report article about the increase in drug overdoses in West Virginia, Research!America board member Georges Benjamin, M.D., executive director, American Public Health Association, commented on the complexity of implementing policies to curb opioid-related deaths in the state and across the country.
U.S. Investments in Medical and Health Research and Development 2013-2016, a comprehensive R&D report from Research!America highlighting investments in medical and health research was the focus of articles in Becker’s Hospital Review, Healthcare Finance and the American Journal of Managed Care.
Research!America board member Nancy Brown, CEO, American Heart Association, was quoted in a Cardiovascular Business article about a partnership between the American Heart Association and Lawrence Livermore National Laboratory to help speed drug discovery through the use of computational and experimental tools.
Medical Device Tax
Research!America Vice President of Policy and Advocacy Ellie Dehoney penned an op-ed in The Morning Consult urging Congress to repeal the medical device tax. “…R&D, including the R&D behind new medical devices, gives a fighting chance to children with EB and others facing life-threatening diseases. We undervalue it at their peril.”
An Inside Health Policy article about calls to repeal the medical device tax quoted Mary Woolley. "By disincentivizing investment in medical device R&D, the medical device tax works against progress toward new medical technologies that can save lives and provide transformative support to individuals with disabilities.”
Research!America board member Susan Dentzer, president and CEO, Network for Excellence in Health Innovation (NEHI), was quoted in The American Journal of Managed Care about a new white paper from NEHI that encourages the use of outcomes-based contracting for novel oncology drugs. “We are in the midst of a revolution in cancer care in which new, more personalized drugs will help many patients, but at high cost.”